Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate by Tianyi Cai (1511026)

“…We find that the kinetics of Na₂CO₃ bulk carbonation is controlled by the <i>I</i>_H⁺/<i>V</i>_Na^– defect pair generation in Na₂CO₃; we predict that the kinetics can be enhanced by doping lithium into Na₂CO₃, which decreases the defect formation energy by 0.13 eV. …”

Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate by Tianyi Cai (1511026)

“…We find that the kinetics of Na₂CO₃ bulk carbonation is controlled by the <i>I</i>_H⁺/<i>V</i>_Na^– defect pair generation in Na₂CO₃; we predict that the kinetics can be enhanced by doping lithium into Na₂CO₃, which decreases the defect formation energy by 0.13 eV. …”

Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity by Sayantan Datta (379869)

Informing Policy and Management in New Zealand Agricultural Regions Using Nitrogen and Oxygen Isotopes to Quantify Hot Spots and Hot Moments of Nitrate Loss. AGU Fall Meeting, San... by W Troy Baisden (6978023)

Reduced control model M2: Only oscillation of the likelihood. by Veith Weilnhammer (2909060)

“…<p>When simulating data for the <i>likelihood-oscillation-only model</i>, we removed the oscillation from the prior term by setting the amplitude <i>a</i>_<i>ψ</i> to 0. …”

Active-Site Models for the Nickel–Iron Hydrogenases: Effects of Ligands on Reactivity and Catalytic Properties by Maria E. Carroll (1821628)

“…The acid-independent rate of reduction of CH₂ClCO₂H by [<b>2</b>H]⁺ is about 50 s^–1 (25 °C), twice that of [<b>1</b>H]⁺. …”

DataSheet1_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.docx by Zehua Zhang (312656)

“…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”

Table1_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.DOCX by Zehua Zhang (312656)

“…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”

The tombusvirus p33 replication protein binds to the yeast Scs2p VAP protein in the ER. by Daniel Barajas (255452)

“…Yeast was grown under similar conditions and images were taken as in panel C. (E) Decreased TBSV repRNA accumulation in <i>scs2Δ</i> yeast. …”

Table2_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.DOCX by Zehua Zhang (312656)

“…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”

Supporting data for "Mechanistic study of TSPYL2 stabilization in <i>TSPYL1 </i>depleted cells" by Xu Luo (12992484)

Table_1_Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.docx by Yanhong Guo (270212)

“…Among those 247 patients with MHD, 211 patients were already in treatment with angiotensin converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARBs) before being treated with sacubitril/valsartan. We also performed an analysis to compare the differences between the 211 patients who had previously received ACEi/ARB treatment and the 36 patients who were sacubitril/valsartan naive.…”

A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain. by Amit Benbenishty (6524375)

“…<p>(<b>a</b>) In the experimental metastasis models, we used the aECAi approach [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006859#pbio.2006859.ref032" target="_blank">32</a>] for injection of tumor cells (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006859#sec002" target="_blank">Methods</a>): a method that improves brain targeting and preserves cerebral hemodynamics. …”

CARM1 drives mitophagy and autophagy flux during fasting-induced skeletal muscle atrophy by Derek W. Stouth (17475753)

<i>d-myc</i> knockdown can rescue the Malpighian tubule defects of <i>BicC</i> mutants. by Chiara Gamberi (499883)

“…(F) Representative d-Myc and tubulin immunoblots of extracts from five Malpighian tubules dissected from flies of the following genotypes: <i>wild-type</i> (<i>wt</i>); heterozygotes for the Gal4 driver <i>c724</i> and <i>c42</i> constructs (<i>Gal4/+</i>); heterozygotes for the d-<i>myc</i>^<i>RNAi</i> construct (<i>myc</i>^<i>RNAi</i>/+); <i>myc</i> RNAi driven by <i>c724</i> and <i>c42</i> (<i>Gal4>myc</i>^<i>RNAi</i>); <i>BicC</i>^{<i>YC33/YC33</i>} homozygotes (<i>BicC</i>^<i>YC33</i>); <i>myc</i> RNAi driven in <i>BicC</i>^<i>YC33</i> homozygotes (<i>BicC</i>^<i>YC33</i>; <i>Gal4>myc</i>^<i>RNAi</i>). …”

<i>EGFR</i> mutation testing, treatment and survival in stage I–III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis by Bharathi Muthusamy (19200092)

Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study by Agaba Katureebe (340952)

“…The addition of three rounds of IRS at ~6-mo intervals in Nagongera was followed by clear decreases in all outcomes: incidence of malaria (3.25 pre-intervention versus 0.63 post-intervention; aRR = 0.13, 95% CI 0.07–0.27, <i>p <</i> 0.001), TPR (37.8% pre-intervention versus 15.0% post-intervention; aRR = 0.54, 95% CI 0.49–0.60, <i>p <</i> 0.001), and HBR (18.71 pre-intervention versus 3.23 post-intervention; aRR = 0.29, 95% CI 0.17–0.50, <i>p <</i> 0.001). …”

PDLB - Balance Sheet by Nguyen Linh (19516642)

“…</p><p><br></p><p dir="ltr">ECIP capital: PDLB received $225M of ECIP capital, and the regulators assigned them the lowest possible dividend (0.5%) on this capital for the first year of payments (announced in June). If we assume PDLB continues to pay 0.5% on this preferred and they have a cost of preferred equity of 10%, then we can calculate the value of this $225M liability as just $11M, with the rest a write-up to equity.…”

Supplemental data of Glucocorticoid Dependent Mesenchymal Cell Differentiation is Required for Perinatal Lung Morphogenesis and Lung Function by Yan Xu (6655778)

“…Cells were pelleted, counted and 50,000 cells per sample prepared for ATAC-seq at a depth of ~1,000,000 reads per sample. …”